The Latest Breaking News from Vaccine

A study suggests mRNA vaccines could help the body fight malignant cells, says Prof Devi Sridhar, chair of global public health at the University of Edinburgh

This advice comes as the UK Health Security Agency (UKHSA) confirms this year’s flu vaccine provides "strong protection"

It comes as flu season has hit early this year.

Researchers in South Africa have launched clinical trials for the first vaccine developed entirely in the country

Doctors step up after US health department suspended its flu vaccine campaign following Trump’s election

‘We need to be more boldly anti-vax,’ one speaker told the crowd of attendees

There were 502 cases of whooping cough between January and June this year in England, according to UKHSA

In the wake of a measles outbreak in Canada that has infected thousands of people over the past year, an international health agency revoked the country’s measles-free status on Nov. 10, 2025.

Vaccine advocates say hospitals are missing an opportunity to help rein in a dangerous outbreak of whooping cough.

Moderna Inc. (NASDAQ:MRNA) reported a third-quarter loss of 51 cents, beating the expected loss of $2.02, a turnaround from an income of 3 cents a year ago.

Moderna, Inc (NASDAQ:MRNA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. MRNA is building positive momentum. Watch the momentum here This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visithttps://www.benzinga.com/apis/for a consultation. Operator…